prediabetes glp 1 Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management Comparing Glucagon‐like peptide‐1 receptor agonists

Setting clear goals for GLP-1 spend and/or usage

You Need Fewer Side Effects: Surprisingly, some patients who felt nauseous on Semaglutide tolerate Tirzepatide much better

A broad spectrum of drugs have been developed to treat Parkinsons symptoms, with dismal success rates

Methods Scoping Review This is a scoping literature review on the extent of research on the combined use of GLP1-RAs and SGLT2is in individuals with T2D

ACE-031 is a protein-based therapeutic designed to promote muscle growth by inhibiting myostatin, a natural regulator that limits muscle development

A study carried out on a group of cyclists showed increased oxidation of fat during submaximal exercise after oral administration of taurine (Rutherford et al., 2010)